11:31 AM EST - KP Tissue Inc. : Reports Q2 2026 financial and operational results. Revenue was $550.9 million in Q2 2026 compared to $536.1 million in Q2 2025, an increase of $14.8 million or 2.8%. Adjusted EBITDA was $90.6 million in Q2 2026 compared to $72.5 million in Q2 2025, an increase of 25.0%. Net income was unchanged at $22.1 million in Q2 2026 compared to $22.1 million in Q2 2025. KP Tissue Inc.
shares T.KPT are trading down $0.05 at $12.72.
